Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
Anne LaurainSophie MetivierGeorges HaourDominique LarreyCéline DorivalChristophe HezodeFabien ZoulimPatrick MarcellinMarc BourliereJean-Pierre ZarskiDominique ThabutLaurent AlricNathalie Ganne-CarriePaul CalesJean-Pierre BronowickiGhassan RiachiClaire GeistXavier CausseArmand AbergelOlivier ChazouilleresPhilippe MathurinDominique GuyaderDidier SamuelAlbert TranVéronique Loustaud-RattiVentzislava Petrov-SanchezAlpha DialloClovis Luzivika-NzingaHélène FontaineFabrice CarratStanislas Polnull nullPublished in: BMC infectious diseases (2019)
Trial registration with ClinicalTrials.gov NCT01953458 .